Authors

• John D. Davis (ORCID: https://orcid.org/0000-0001-6282-1670)
• Shazia Ali
• Andrea T. Hooper (ORCID: https://orcid.org/0000-0003-1131-1229)
• Cynthia X. Pan (ORCID: https://orcid.org/0000-0003-1471-973X)
• Ned Braunstein
• Samit Ganguly (ORCID: https://orcid.org/0000-0002-3037-1959)
• Jesse T. Chao (ORCID: https://orcid.org/0000-0002-6995-9581)
• Edward Cox (ORCID: https://orcid.org/0000-0001-8981-0699)
• Rafia Bhore
• Thomas Norton (ORCID: https://orcid.org/0009-0004-5896-9057)
• Mazhar Thakur
• Jennifer D. Hamilton (ORCID: https://orcid.org/0000-0003-1236-5245)
• Paula Dakin (ORCID: https://orcid.org/0000-0002-8925-0414)
• Danise Subramaniam
• Bari Kowal
• Gregory P. Geba (ORCID: https://orcid.org/0000-0001-8936-748X)
• Joseph A. Bocchini
• Alpana Waldron
• Gary Herman (ORCID: https://orcid.org/0000-0003-4433-6529)
• Jing Xiao
• Yogesh S. Patel
• Dominique Atmodjo-Watkins
• K. C. Turner
• A. Thomas DiCioccio
• Susan C. Irvin

Institutions

• Regeneron (United States) (US)
• Willis-Knighton Cancer Center (US)

Publication Details

Journal

BMJ Open

Published

2024-10-01

DOI

https://doi.org/10.1136/bmjopen-2024-087431

Primary Topic

COVID-19 Impact on Reproduction

Type

article

Field-Weighted Citation Impact

0.00

Funders

• U.S. Department of Health and Human Services
• F. Hoffmann-La Roche
• Regeneron Pharmaceuticals
• Biomedical Advanced Research and Development Authority